At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis
In Brief
A clinical study evaluating Anastrozole, flaxseed, and 1 other intervention for Breast Cancer. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The proposed study plans to examine the effect of flaxseed consumption, a phytoestrogen rich food, compared to aromatase inhibitors as a complementary approach to treating estrogen receptor positive breast cancer, as well as the effect of combined flaxseed and aromatase inhibitor therapy on breast cancer treatment. Because of the increasing use of both complementary and alternative approaches to treatment, and the use of aromatase inhibitors in the treatment of breast cancer, the proposed study has potential to provide important clinical information about the effect of foods high in phytoestrogens on a common endocrine therapy used in breast cancer.
Study Details
Timeline
Interventions
1 mg per day
25 g per day ground
Placebo pill 1 per day